Pfizer in Early Talks to Acquire Biotech Firm Seagen for Over $30 Billion

On February 27, according to The Wall Street Journal, Pfizer, Inc. is in talks to acquire Seagen, Inc., people familiar with the matter said.The price may exceed $30 billion.The negotiations are still in the early stages and may not necessarily lead to an agreement.